NEFL and amyotrophic lateral sclerosis: In contrast to baseline pNFH, baseline serum NFL both predicts survival and improves prediction of longitudinal ALSFRS-R slope relative to the information provided by the initial ALSFRS-R slope only: these two features qualify serum NFL as a true prognostic biomarker for ALS.